Actualités Protagonist Therapeutics - PTGX

Les meilleurs offres pour accéder les cours en temps réel en illimité
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Expert
Abonnement Mensuel
Seulement
92,39 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Protagonist Therapeutics Inc PTGX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  -0,009 -0,12% 7,621 7,68 7,41 7,60 7,63 16:52:04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/12/201900:46EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:33EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:12EDGARStatement of Changes in Beneficial Ownership (4)
04/12/201900:11EDGARStatement of Changes in Beneficial Ownership (4)
03/12/201913:51EDGARCurrent Report Filing (8-k)
03/12/201913:00PRNUSProtagonist Therapeutics Announces Preliminary Phase 2..
27/11/201923:20EDGARCurrent Report Filing (8-k)
27/11/201923:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
27/11/201920:59EDGARStatement of Changes in Beneficial Ownership (4)
25/11/201912:05EDGARNotice of Effectiveness (effect)
13/11/201913:00PRNUSProtagonist Therapeutics to Present at Two Upcoming..
06/11/201923:13EDGARQuarterly Report (10-q)
06/11/201922:35EDGARCurrent Report Filing (8-k)
06/11/201922:30PRNUSProtagonist Therapeutics Reports Third Quarter 2019..
06/11/201922:01PRNUSProtagonist Therapeutics Announces First Patient Dosed in a..
31/10/201922:26EDGARSecurities Registration Statement (simplified Form) (s-3)
31/10/201921:52EDGARCurrent Report Filing (8-k)
31/10/201912:00PRNUSProtagonist Therapeutics Secures Debt Facility for up to $50..
30/10/201921:49PRNUSProtagonist Therapeutics Initiates Phase 2 Study of Novel..
01/10/201913:00PRNUSProtagonist Therapeutics Announces Acceptance of Abstracts..
25/9/201913:00PRNUSProtagonist Therapeutics to Present at the Cantor Global..
04/9/201922:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
03/9/201922:30PRNUSProtagonist Therapeutics to Present at the H.C. Wainwright &..
07/8/201923:23EDGARQuarterly Report (10-q)
07/8/201915:29EDGARCurrent Report Filing (8-k)
07/8/201913:00PRNUSProtagonist Therapeutics Reports Second Quarter 2019..
01/8/201922:30PRNUSOral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates..
16/7/201922:05PRNUSProtagonist Therapeutics Reports Granting of Inducement..
01/7/201922:51EDGARStatement of Ownership (sc 13g)
18/6/201922:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
17/6/201922:07EDGARStatement of Ownership (sc 13g)
17/6/201913:00PRNUSProtagonist Therapeutics to Present at the BMO 2019..
13/6/201922:02EDGARCurrent Report Filing (8-k)
12/6/201900:34EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201900:32EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201900:30EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201900:28EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201900:27EDGARStatement of Changes in Beneficial Ownership (4)
12/6/201900:21EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201913:00PRNUSProtagonist Therapeutics Reports Granting of Inducement..
04/6/201901:40EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201901:36EDGARInitial Statement of Beneficial Ownership (3)
29/5/201922:51EDGARCurrent Report Filing (8-k)
29/5/201922:30PRNUSProtagonist Therapeutics Appoints Don Kalkofen as Chief..
17/5/201900:45EDGARStatement of Changes in Beneficial Ownership (4)
14/5/201913:00PRNUSOral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates..
13/5/201923:19EDGARCurrent Report Filing (8-k)
08/5/201922:37EDGARQuarterly Report (10-q)
08/5/201916:24DJNProtagonist Shares Up 17% After Expanded Janssen Agreement
08/5/201913:09EDGARCurrent Report Filing (8-k)
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NASDAQ
PTGX
Protagonis..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20191210 16:09:32